412 Pathological validation of adjuvant anti-fibroblast growth factor receptor 3 (FGFR3) treatment for bladder cancer

✍ Scribed by Neuzillet, Y.; Mertens, L.; Shariat, S.; Bostrom, P.; Mirtti, T.; Sagalowsky, A.; Ashfaq, R.; Broeks, A.; Horenblas, S.; Hurst, C.; Tomlinson, D.; Knowles, M.; Bapat, B.; Jewett, M.; Zlotta, A.; Sanders, J.; Lotan, Y.; Van Der Kwast, T.; Van Rhijn, B.

• Book ID: 122173398
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 111 KB
• Volume: 13
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(14)60407-3